MPS VI Recruiting Phase 1 Trials for Galsulfase (DB01279)

IndicationStatusPhase
DBCOND0053627 (MPS VI)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04532047
In Utero Enzyme Replacement Therapy for Lysosomal Storage DiseasesTreatment